GIFLF:OTCMKTS
grifols
11,13 US$
0,00%
(0,00) 1D
15 სექ, 15:11:14 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIFLF...
Mkt. cap
6,59 მლრდ.
Avg. vol.
543,00
Volume
0,00
52-wk high
12,90 US$
52-wk low
10,13 US$
Beta
0,90
Shares outstanding
426,13 მლნ.
No. of employees
25 ათ.
Mkt. cap
6,59 მლრდ.
Avg. vol.
543,00
Volume
0,00
52-wk high
12,90 US$
52-wk low
10,13 US$
Beta
0,90
Shares outstanding
426,13 მლნ.
No. of employees
25 ათ.
News stories
From web sources and news partners
AD HOC NEWS
·
1 დღის წინ
Grifols stock ends the week at EUR 9.88 within a EUR 9.73-9.97 range
AD HOC NEWS
·
1 დღის წინ
Grifols stock after-hours at EUR 9.88: plus 0.51 percent
AD HOC NEWS
·
2 დღის წინ
Grifols signed a 40 GWh PPA and Grifols stock gained 1.22 percent
AD HOC NEWS
·
2 დღის წინ
Grifols stock pre-market at EUR 9.83: unchanged
Profile
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
About grifols